Generate Biomedicines

IPO

Now we can.

Public · Cambridge, United States · Founded 2018 · $693.0M raised

Employees
201–500
Founded
2018
Business Model
B2B
Total Funding
$693.0M
Last Round
Corporate RoundDec 2024
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Generate Biomedicines is a therapeutics company pioneering Generative Biology — existing at the intersection of machine learning, biological engineering, and medicine. Their Generate Platform uses AI trained on 160,000 protein structures and 190 million genetic sequences to design novel protein-based therapeutics. The company aims to radically transform drug discovery by generating medicines rather than searching for them.

Summary

Generate Biomedicines is an Artificial Intelligence company based in Cambridge, United States, founded in 2018. It has raised $693.0M in total across 4 rounds, most recently a Corporate Round in Dec 2024. Investors include Flagship Pioneering, Samsung Venture Investment Corporation and Abu Dhabi Investment Authority.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOFeb 2026
$400.0M

Sign up to see all 5 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Generate Biomedicines on Indexed.vc
<a href="https://indexed.vc/companies/generate-biomedicines"><img src="https://indexed.vc/api/badge/company/generate-biomedicines" alt="Generate Biomedicines on Indexed.vc" width="260" height="76" /></a>